Quick Answer: Tirzepatide does not cause vaginal spotting according to FDA prescribing information and clinical trial data
Weight loss doesnt affect sexual function Myth: Losing weight has no impact on erections or libido
Beyond glycemic control, the pleiotropic actions of GLP-1 on various organs and metabolic pathways are emphasized, underscoring its potential utility in addressing cardiovascular, renal, and obesity-related complications
Under this approach, if prescription drug manufacturers negotiate a special deal with the federal government, they can offer the prices for brand prescriptions established under that deal
222,224233 Notably, probiotics can be utilized to modify the gut microbiota targeting TMAO, but the impact of different strains on TMAO levels varies
Key Tips for Plan Sponsors: Evaluate GLP-1 coverage for weight loss in your benefit plan